REG - BSF Enterprise PLC - Annual Financial Report - Correction

BSF EnterpriseAnnouncement

03/02/2026 17:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260203:nRSC5716Ra&default-theme=true

RNS Number : 5716R  BSF Enterprise PLC  03 February 2026

3 February 2026

 

BSF Enterprise PLC

("BSF" or the "Company")

Annual Report and Accounts - Correction

 

BSF Enterprise PLC (LSE: BSFA), a leading innovator in tissue-engineered
materials, advises in relation to its Annual Report and Consolidated Financial
Statements for the year ended 30 September 2025 released yesterday, that there
is a correction to the RNS Highlights and on page 6 of the report in the first
paragraph of the Financial Summary where the net loss of £1,013,527 should be
£1,113,527.

 

The Annual Report is available to view on the Company's website at:
https://bsfenterprise.com/reports-documents-and-presentations#reports
(https://bsfenterprise.com/reports-documents-and-presentations#reports)

 

 

 BSF Enterprise PLC

 Geoff Baker - Chairman

 Che Connon - CEO & Director
 Shard Capital (Broker)

 Damon Heath                       0207 186 9000

 Isabella Pierre                   0207 186 9927
 AlbR Capital Limited (Broker)     +44 (0)20 7469 0930

 Colin Rowbury

 Jon Belliss
 ISIN of the Ordinary Shares

 is GB00BHNBDQ51.

 SEDOL Code is BHNBDQ5.

 

 

About BSF Enterprise PLC

BSF Enterprise PLC (BSF) develops and commercialises cutting-edge
tissue-engineered solutions, including lab-grown leather, cultivated meat, and
corneal repair technologies. By leveraging its proprietary scaffold-free
platform, BSF aims to deliver sustainable alternatives to traditional
materials and meet global demand for environmentally responsible innovations.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCEXLFBQLLBBBQ



            Copyright 2019 Regulatory News Service, all rights reserved